A Belgian cell therapy company has secured $60 million in funding to strengthen its manufacturing operations, and grow the cell and gene therapy ecosystem across the world. Ncardia landed the funding…
BAKX Therapeutics emerged from stealth in a big way back in July, striking an $852 million deal with Ipsen for its lead cancer candidate, a small molecule designed to activate the body’s natural…
The holding company of a South Korean vaccine maker is in the final talks to make an investment into a US gene therapy firm. SK Biosciences is in the process of signing a deal with the Center for…
Endo International is expanding its manufacturing capacity at a subsidiary to help out the US national stockpile, and it’s getting funding from the government to do so. Par Sterile Products will…
The way BridgeBio tells it, it’s been up to some big things recently. And on Thursday, the biotech just got a whole lot more cash to turn its dreams into reality. BridgeBio took out a $750 million…
A new cell and gene therapy testing facility in Philadelphia’s Navy Yard is officially opened, WuXi ATU announced Monday. The new facility includes 140,000 square feet worth of laboratories, and will…
As the future of machine learning and AI promises to make major breakthroughs in drug development, a suite of startups is looking to scale their own competing robot brain trusts. An ambitious startup…
A bill has been introduced into Congress to establish a competitive grant program to award money to manufacturers with the goal of establishing training centers and upping production capacity in order…
Early this year researchers at Novo Nordisk were beaming as they announced the first drug identified in their RNAi alliance with Dicerna was headed into the clinic. And now they’re coming back for the…
RBC analyst Brian Abrahams is back with an update on the death of an Alzheimer’s patient on Biogen’s controversial aducanumab, and this time he says that there are solid reasons to believe that the…
